Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5

Br J Pharmacol. 1997 Nov;122(5):796-8. doi: 10.1038/sj.bjp.0701468.

Abstract

The effects of descarboethoxyloratadine (DCL), the major metabolite of loratadine, were studied on a human cardiac K+ channel (hKv1.5) cloned from human ventricle and stably expressed in a mouse cell line by means of the patch-clamp technique. DCL (1-100 microM) inhibited hKv1.5 current in a concentration-dependent manner with an apparent affinity constant of 12.5+/-1.2 microM. The blockade increased steeply over the voltage range of channel opening, which indicated that DCL binds preferentially to the open state of the channel. At more depolarized potentials a weaker voltage-dependence was observed consistent with a binding reaction sensing approximately 20% of the transmembrane electrical field. DCL, 20 microM, increased the time constant of deactivation of tail currents, thus inducing a 'crossover' phenomenon. The present results demonstrated that DCL blocked hKv1.5 channels in a concentration-, voltage-, and time-dependent manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Dose-Response Relationship, Drug
  • Heart Ventricles
  • Humans
  • Ion Channel Gating
  • Kv1.5 Potassium Channel
  • Loratadine / metabolism*
  • Membrane Potentials / drug effects
  • Mice
  • Patch-Clamp Techniques
  • Piperidines / pharmacology*
  • Potassium Channel Blockers*
  • Potassium Channels*
  • Potassium Channels, Voltage-Gated*
  • Pyridines / pharmacology*

Substances

  • KCNA5 protein, human
  • Kcna5 protein, mouse
  • Kv1.5 Potassium Channel
  • Piperidines
  • Potassium Channel Blockers
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • Pyridines
  • Loratadine
  • desloratadine